C.R. Bard (NYSE:BCR) acquired Minneapolis-based angioplasty balloon maker Lutonix Inc. for $325 million.
The merger, announced during Bard’s 2012 guidance update conference call, grants Lutonix $225 million up front with another $100 million when Lutonix achieves pre-market approval for its drug-coated balloons.
Microcatheter maker iScience Interventional announced an investment by med-tech goliath Medtronic Inc. (NYSE:MDT) to support the commercialization of its drug delivery technologies.
The Menlo Park, Calif.-based company’s microcatheter is used during the surgical treatment of glaucoma to deliver drugs to the eye.
Calypso Medical Technologies Inc. raised $6.4 million from what it hopes will be a $7.5 million funding round.
Twenty-seven unnamed investors have participated in the debt and options-based round thus far. The first sale of securites occured on Jan. 6, according to a Securities & Exchange Commission filing.
iMedX bought out Louisiana-based healthcare transcription firm MedTech Transcriptions Inc. for an undisclosed amount.
The acquisition allows the Shelton, Conn.-based healthcare software and services company to expand its customer base in the Pelican State.
MassDevice Network
@MassDevice
LinkedIn
YouTube